American Oriental Bioengineering, Inc. (AOBI)
OTCMKTS · Delayed Price · Currency is USD
0.0130
+0.0118 (983.33%)
At close: Aug 13, 2026
AOBI Market Cap
AOBI has a market cap or net worth of $949 as of October 16, 2026. It is the 52,401st most valuable company in the world and the 8,435th biggest in the United States. Its market cap has increased by 2,536.11% in one year.
Market Cap
949.00
Enterprise Value
n/a
Revenue
121.58M
Global Rank
Country Rank
#8,435 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2002, AOBI's market cap has decreased from 4.00M to 949.00, a decrease of -99.98%. That is a compound annual growth rate of -29.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 949.00 | 136.66% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| EV Biologics | 1.02K |
| eFFECTOR Therapeutics | 941.00 |
| Proteonomix | 791.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |